Viral Kansara
Company: Clearside Biomedical Inc.
Job title: Vice President of Preclinical Development
Seminars:
AMD: Targeted Suprachoroidal Access for Safer, More Precise Chorio- Retinal Drug Administration 10:15 am
Comparing suprachoroidal delivery to conventional intravitreal injections: advantages in localizing therapy closer to disease sites with potentially improved safety profiles Exploring how suprachoroidal administration may limit anterior segment exposure and systemic circulation, reducing off-target effects Evaluating the potential to combine suprachoroidal delivery with gene therapy, small molecules, and sustained-release formulations to enhance efficacyRead more
day: Day2
Chair’s Opening Remarks 8:20 am
day: Day1